SCHEMBL23648174

SCHEMBL23648174

O=c1c2ccccc2sc2c(OCCO)c(OCCO)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.43
MAPT P10636 4/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
HCRTR1 O43613 1/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
PTPN1 P18031 2/20 0.39
PTPN2 P17706 1/20 0.39
CYP19A1 P11511 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30173373 1.00 IDO1 (0.43) IDO1MAPTALDH1A1L3MBTL1LMNA
SCHEMBL30291035 0.84 MAPT (0.40) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL23647933 0.84 MAPT (0.40) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL23787459 0.83 MAPT (0.40) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL30173371 0.82 MAPT (0.44) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL13164766 0.81 MAPT (0.50) IDO1MAPTALDH1A1L3MBTL1LMNA
SCHEMBL21624276 0.80 F9 (0.43) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL30017437 0.80 F9 (0.43) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL21635970 0.80 MAPT (0.40) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL13066138 0.78 MAPT (0.40) IDO1MAPTALDH1A1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230082557-A1 Modified Thioxanthone Photoinitiators LINTFIELD LIMITED (GB) 2023-03-16 US claimed
EP-4090656-A1 MODIFIED THIOXANTHONE PHOTOINITIATORS Lintfield Limited (GB) 2022-11-23 EP claimed
WO-2021144582-A1 MODIFIED THIOXANTHONE PHOTOINITIATORS LINTFIELD LIMITED (GB) 2021-07-22 WO claimed
US-12535735-B2 Modified thioxanthone photoinitiators LINTFIELD LIMITED (GB) 2026-01-27 US disclosed
US-20230082557-A1 Modified Thioxanthone Photoinitiators LINTFIELD LIMITED (GB) 2023-03-16 US disclosed
WO-2021144582-A1 MODIFIED THIOXANTHONE PHOTOINITIATORS LINTFIELD LIMITED (GB) 2021-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230082557-A1 Modified Thioxanthone Photoinitiators TPMT, PPOX, TST IDO1 1132/4885MAPT 352/4885ALDH1A1 874/4885
US-12535735-B2 Modified thioxanthone photoinitiators FTO, UGT1A6, TPMT IDO1 2885/4885MAPT 2905/4885ALDH1A1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.